Quantbot Technologies’s Ovid Therapeutics OVID Stock Holding History

Quantbot Technologies’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,400	Closed	-$53K	–	1755
2021 Q1	$53K	Buy	+13,400	New	+$44.5K	0.01%	1001

Other funds holding OVID

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantbot Technologies's OVID Position: Q2 2021 in Review

Quantbot Technologies sold out of Ovid Therapeutics (OVID) in Q2 2021, closing a stake of 13,400 shares — an estimated $53K sold.

Quantbot Technologies first reported a position in OVID in Q1 2021 and held it in 1 quarter. The position peaked at $53K in Q1 2021. 80 funds tracked by Wall St. Rank hold OVID as of Q2 2021.

Quantbot Technologies reported no remaining Ovid Therapeutics position as of Q2 2021 after selling out during the quarter.
Quantbot Technologies sold 13,400 Ovid Therapeutics shares in Q2 2021, an estimated $53K.
Quantbot Technologies first reported a position in Ovid Therapeutics in Q1 2021 and held it in 1 quarter.
Quantbot Technologies's Ovid Therapeutics position peaked at $53K in Q1 2021.
80 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2021.

Based on Quantbot Technologies's 13F filing for Q2 2021, filed 12 Aug 2021.